Mark W Majesky

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 5

Top Topics

Pulmonary Artery

Positive Breast Cancer

Top Venues

bioRxiv : the preprint server for biology

Arteriosclerosis, thrombosis, and vascular biology

Journal of muscle research and cell motility

This page only lists publications with an associated author ORCID identifier.

Publications

Sizhao Lu, Austin J Jolly, Allison M Dubner, Keith A Strand, Marie F Mutryn, Tyler Hinthorn, Tysen Noble, Raphael A Nemenoff, Karen S Moulton, Mark W Majesky, Mary C M Weiser-Evans
KLF4 in smooth muscle cell-derived progenitor cells is essential for angiotensin II-induced cardiac inflammation and fibrosis. bioRxiv : the preprint server for biology (2024)
Allison M Dubner, Sizhao Lu, Austin J Jolly, Tysen Noble, Tyler Hinthorn, Raphael A Nemenoff, Karen S Moulton, Mark W Majesky, Mary C M Weiser-Evans
Confounding Effects of Tamoxifen: Cautionary and Practical Considerations for the Use of Tamoxifen-Inducible Mouse Models in Atherosclerosis Research. Arteriosclerosis, thrombosis, and vascular biology (2023)
Maxwell C McCabe, Daryl M Okamura, Christopher B Erickson, Blair W Perry, Chris M Brewer, Elizabeth D Nguyen, Anthony J Saviola, Mark W Majesky, Kirk C Hansen
ECM-Focused Proteomic Analysis of Ear Punch Regeneration in Acomys Cahirinus . bioRxiv : the preprint server for biology (2023)
Daryl M Okamura, Elizabeth D Nguyen, Sarah J Collins, Kevin Yoon, Joshua B Gere, Mary C M Weiser-Evans, David R Beier, Mark W Majesky
Mammalian organ regeneration in spiny mice. Journal of muscle research and cell motility (2022)
Hisashi Sawada (澤田悠), Yuriko Katsumata, Hideyuki Higashi, Chen Zhang, Yanming Li, Stephanie Morgan, Lang Ho Lee, Sasha A Singh, Jeff Z Chen, Michael K Franklin, Jessica J Moorleghen, Deborah A Howatt, Debra L Rateri, Ying H Shen, Scott A LeMaire, Masanori Aikawa, Mark W Majesky, Hong S Lu (吕红), Alan Daugherty
Second Heart Field-Derived Cells Contribute to Angiotensin II-Mediated Ascending Aortopathies. Circulation 145 (13) (2022)